Plain-English translation of NCT05649865 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study is testing whether measuring HPV DNA in your blood can help doctors better understand how your throat cancer is responding to treatment and catch any return of cancer earlier than current methods allow. Researchers will collect blood samples from you before, during, and after your cancer treatment to see if these blood tests could eventually replace or improve upon the imaging scans doctors currently use to monitor your progress.
Currently, doctors use imaging scans 12 weeks after treatment to see if your cancer responded well, but these scans can sometimes be unclear or miss very early signs of cancer coming back. This study exists to find out whether tracking HPV DNA in your blood could give doctors a clearer, earlier warning of treatment success or cancer recurrence — which might help catch problems sooner when treatment options are most effective.
You likely qualify if…
You likely don't qualify if…
You will give blood samples at multiple points: before your cancer treatment starts, during treatment, and after treatment ends. These blood tests will be done alongside your regular cancer care visits, so you won't need extra appointments just for this study. Researchers will track the HPV DNA levels in your blood over time to see how well your treatment is working and to watch for any early signs of cancer returning.
AI-generated summary from trial data · Jun 24, 2026 · Not medical advice
Sweden